Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated Cardiotoxicity

Benjamin Buck(The Ohio State University Wexner Medical Center), Daniel Addison(The Ohio State University Wexner Medical Center), Tracy Wiczer(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jennifer A. Woyach(The Ohio State University), Orlando P. Simonetti(The Ohio State University), Haseeb Nawaz(Southern Illinois University School of Medicine), John Alan Gambril(The Ohio State University Wexner Medical Center), Patrick Ruz(The Ohio State University Wexner Medical Center), Lai Wei(University of Tennessee Health Science Center), Subha V. Raman, Kerry A. Rogers(The Ohio State University), Avirup Guha(The Ohio State University Wexner Medical Center), Seema A. Bhat(The Ohio State University), Farrukh T. Awan(The Ohio State University), Janice M. Bonsu(The Ohio State University Wexner Medical Center), Adam S. Kittai(The Ohio State University Wexner Medical Center), Grant M. Wallace(The Ohio State University Wexner Medical Center), James W. Mann(The Ohio State University Wexner Medical Center), Aaron Chum(The Ohio State University Wexner Medical Center), Mitkumar Patel(The Ohio State University Wexner Medical Center), Devin Haddad(The Ohio State University Wexner Medical Center), Rebecca Carter(The Ohio State University Wexner Medical Center), Reynaldo Sanchez(The Ohio State University Wexner Medical Center), John C. Byrd(The Ohio State University), Vedat Yildiz(The Ohio State University), Onaopepo Kola‐Kehinde(The Ohio State University Wexner Medical Center)
JAMA Oncology
February 2, 2023
Cited by 29


Related Papers